May 15, 2020 08:44 AM EDT

Cherry Thomas joins Caribou as SVP of clinical development; Artax locks in Joseph Lobacki as CEO

Kathy Wong

Editor

Alex Hoffman

Copy Chief

→ CRISPR genome editing player Caribou Biosciences has appointed Cherry Thomas as SVP of clinical development, a newly-created position. Thomas …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Cherry Thomas joins Caribou as SVP of clinical development; Artax locks in Joseph Lobacki as CEO

Kathy Wong

Editor

Alex Hoffman

Copy Chief

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

FDA approves first drug to treat ultra-rare lipid storage disease

Will CRISPR matter?

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Cher­ry Thomas joins Cari­bou as SVP of clin­i­cal de­vel­op­ment; Ar­tax locks in Joseph Lobac­ki as CEO

Editor

Copy Chief

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Cherry Thomas joins Caribou as SVP of clinical development; Artax locks in Joseph Lobacki as CEO